drugset / Trial / NCT03835871

Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Mild to Moderate Persistent Asthma

NCT03835871

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Approximately 480 (120 per group) would need to complete the 12 weeks of treatments.

Timeline

Start
2019-02
Primary completion
2019-12
Completion
2020-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Beclomethasone Small molecule 100 ug Inhaled
Subject Beclomethasone Small molecule 200 ug Inhaled
Subject Beclomethasone Small molecule 400 ug Inhaled

Indications